Featured series 
Tag: Johanna Seddon
-
Health
Higher levels of systemic inflammatory markers associated with progression of AMD
Researchers led by Johanna M. Seddon, M.D., at the Massachusetts Eye and Ear Infirmary, Harvard Medical School, and Harvard School of Public Health, conducted a prospective longitudinal study to examine several biomarkers for cardiovascular disease, including CRP and IL-6, to measure the relationship between these biomarkers and incidence rates of progression of AMD. They found…
-
Health
Largest twin study of age-related macular degeneration finds genetics and environment play large role in disease
Researchers led by Johanna M. Seddon, M.D., at the Massachusetts Eye and Ear Infirmary, Harvard Medical School and Harvard School of Public Health conducted the largest study of twins of its kind. Analyses of twins showed that genetic factors play a substantial role in the etiology of AMD and associated macular characteristics, explaining 46 percent…
-
Health
Hormone replacement therapy may lower degenerative eye disease risk in postmenopausal women
ARM is a degenerative eye disease that affects the macula, which is responsible for central vision, which is necessary for reading, driving and recognizing people’s faces. Advanced ARM is the leading cause of irreversible blindness among elderly individuals worldwide. Approximately 1.7 million people have decreased vision due to ARM, and 200,000 people develop advanced ARM…
-
Health
Snack foods may increase risk of age-related sight loss
Macular degeneration results from the malfunctioning or loss of function of photo-sensitive cells in the retina. According to the Macular Degeneration Foundation, more than 13 million people in the United States are affected; a new case of adult macular degeneration is diagnosed in the U.S. every three minutes. A study in the August 2001 issue…